Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Eczema/Dermatoses”

151 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 151 results

Testing effectiveness (Phase 2)Looking for participantsNCT06855745
What this trial is testing

Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.

Who this might be right for
Atopic Dermatitis (Eczema)Atopic Dermatitis EczemaAtopic Dermatitis+3 more
Alphyn Biologics 72
Early research (Phase 1)Study completedNCT03733353
What this trial is testing

EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

Who this might be right for
PsoriasisAtopic Dermatitis
Evelo Biosciences, Inc. 204
Post-approval studies (Phase 4)Study completedNCT00509990
What this trial is testing

Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 200
Early research (Phase 1)Study completedNCT02379507
What this trial is testing

DEC033 Study Product for Mild to Moderate Eczema An Open-label, Adaptive-design Pilot Study

Who this might be right for
Eczema
Medicus Research, LLC 20
Early research (Phase 1)Study completedNCT04927195
What this trial is testing

Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma

Who this might be right for
Atopic DermatitisPsoriasisAsthma
Evelo Biosciences, Inc. 52
Testing effectiveness (Phase 2)Study completedNCT01223222
What this trial is testing

Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection

Who this might be right for
Gram-positive, Skin InfectionsMild Eczema/DermatosesAtopic Dermatitis
Lytix Biopharma AS 24
Testing effectiveness (Phase 2)Study completedNCT04504279
What this trial is testing

Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Forte Biosciences, Inc. 154
Large-scale testing (Phase 3)Study completedNCT00120523
What this trial is testing

5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
MEDA Pharma GmbH & Co. KG 2,418
Large-scale testing (Phase 3)Study completedNCT05608343
What this trial is testing

This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)

Who this might be right for
Atopic Dermatitis
Acrotech Biopharma Inc. 153
Testing effectiveness (Phase 2)Study completedNCT02583022
What this trial is testing

Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amorepacific Corporation 74
Not applicableStudy completedNCT02357940
What this trial is testing

Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema

Who this might be right for
Atopic Dermatitis (AD)
Johnson & Johnson Consumer Inc. (J&JCI) 41
Testing effectiveness (Phase 2)Study completedNCT02068352
What this trial is testing

Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Otsuka Pharmaceutical Development & Commercialization, Inc. 121
Testing effectiveness (Phase 2)Study completedNCT06309355
What this trial is testing

Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Hangzhou Yirui Pharmaceutical Technology Co., Ltd 35
Not applicableStudy completedNCT05770271
What this trial is testing

The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and Psoriasis

Who this might be right for
Groin InfectionNeurodermatitisPsoriasis+1 more
Dove Medical Press Ltd 21
Post-approval studies (Phase 4)Study completedNCT00510003
What this trial is testing

Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 117
Early research (Phase 1)UnknownNCT05843422
What this trial is testing

A First-in-Human Study of QY211 Gel in Adult Subjects

Who this might be right for
Atopic Dermatitis
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. 56
Testing effectiveness (Phase 2)Study completedNCT02001181
What this trial is testing

Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)

Who this might be right for
Dermatitis, Atopic
Pfizer 69
Testing effectiveness (Phase 2)Ended earlyNCT04936113
What this trial is testing

Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study

Who this might be right for
Atopic Dermatitis
Forte Biosciences, Inc. 36
Large-scale testing (Phase 3)Study completedNCT03107611
What this trial is testing

Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Mylan Inc. 654
Post-approval studies (Phase 4)Study completedNCT00460083
What this trial is testing

Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Ceragenix Pharmaceuticals 35
Next Page